The search for novel targets to treat metabolic diseases is ongoing as shown by a very recent study which identified neurokinin 2 receptor, a Gs- and Gq-coupled receptor, as another potentially relevant protein for the regulation of body weight and blood glucose (Sass et al, 2024). This evidence concerns the gene TACR2 and metabolic disease.